--- Query Results --- | |||||||||
Organization: | Alberta Precision Laboratories | ||||||||
Message Alert: | PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing. | ||||||||
Test Name/Synonym: | Oligosaccharides Screen (Synonyms: Oligosaccharidoses, Lysosomal Storage Disorders) | ||||||||
Clinical Indications: | This test is for the screening of several oligosaccharide degradation disorders and should be ordered when appropriate clinical presentations are identified. | ||||||||
Ordering Alert: | This test is considered specialty testing and should NOT be ordered without appropriate clinical indications.
This is a qualitative screening test for multiple oligosaccharidosis that may not identify a single disorder. Abnormal results should be confirmed by targeted enzyme or molecular genetic tests based on clinical presentation. | ||||||||
LABID (Connect Care): | LAB4029A | ||||||||
Test Code: |
| ||||||||
Specimen Type: | Urine | ||||||||
Primary Container: | Sterile Container | ||||||||
Alternate Containers: | Non Sterile Container | ||||||||
Minimum Collection Volume: | 5.0 mL | ||||||||
Specimen Collection Requirements: | Collect a 5 to 10 mL random urine specimen. | ||||||||
Test Resources: | Submit request using the applicable requisition or Connect Care online order entry:
| ||||||||
Stability and Storage: | Frozen | ||||||||
Processing: | Specimen can be submitted in primary container or aliquot tube. If specimen is transferred to secondary aliquot tube or container, write "urine" on label. Freeze specimen immediately. | ||||||||
Transportation: | Transport frozen specimens on dry ice. Samples must not thaw during transport. | ||||||||
Method: | Thin layer chromatography (TLC) | ||||||||
Method and Interpretation of Results: | Oligosaccharide pattern is determined using TLC and orcinol staining protocol. Patterns are visually assessed and interpretive report is provided.
Abnormal patterns can occur naturally during pregnancy, in breast-feeding infants or in individuals ingesting infant formula or food replacement containing oligosaccharides. Consider routine testing outside of these scenarios if possible. Abnormal pattern will reflex to include a referred out test for confirmation if sample volume is sufficient. | ||||||||
Routine Turn Around Time: | 10 days | ||||||||
Testing Schedule: | Weekly | ||||||||
Reference Interval: | Interpretation provided on report. | ||||||||
Testing Area: | Biochemical Genetics | ||||||||
Performing Site: | University of Alberta Hospital | ||||||||
Contact Comments: | Newborn Screening & Biochemical Genetics 780-407-8820 | ||||||||
Last Updated On: | Monday, September 12, 2022 | ||||||||
Date of Last Review: | Aug 1 2022 12:00AM | ||||||||